2021
DOI: 10.3390/ijms22147387
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Opioid Receptor Blockade Enhances Epithelial Damage in Piroxicam-Accelerated Colitis in IL-10-Deficient Mice

Abstract: Mucosal CD4+ T lymphocytes display a potent opioid-mediated analgesic activity in interleukin (IL)-10 knockout mouse model of inflammatory bowel diseases (IBD). Considering that endogenous opioids may also exhibit anti-inflammatory activities in the periphery, we examined the consequences of a peripheral opioid receptor blockade by naloxone-methiodide, a general opioid receptor antagonist unable to cross the blood–brain barrier, on the development of piroxicam-accelerated colitis in IL-10-deficient (IL-10-/-) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 69 publications
0
7
0
Order By: Relevance
“…IL-10 is known as anti-inflammatory cytokine generated by Th2 lymphocytes and Treg cells, which plays an essential role in the orchestration of gastrointestinal homeostasis and immune tolerance [ 31 , 32 ]. Previous in vivo experiments have demonstrated that IL-10 can promote and maintain intestinal tolerance to microbiota by modulating Th1/Th17 effector responses [ 30 , 33 ]. IL-10 also plays a vital role in maintaining intestinal homeostasis [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…IL-10 is known as anti-inflammatory cytokine generated by Th2 lymphocytes and Treg cells, which plays an essential role in the orchestration of gastrointestinal homeostasis and immune tolerance [ 31 , 32 ]. Previous in vivo experiments have demonstrated that IL-10 can promote and maintain intestinal tolerance to microbiota by modulating Th1/Th17 effector responses [ 30 , 33 ]. IL-10 also plays a vital role in maintaining intestinal homeostasis [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Defects of IL-10, IL-10-receptor-A and IL-10-receptor-B genes represent a major cause of early-onset IBD [ 35 , 36 ]. Furthermore, mice with lacking IL-10 and IL-10R are more likely to develop spontaneous colitis [ 21 , 33 , 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“… 133 Indeed, both IL-10- and IL-10R-deficient mice can develop spontaneous colitis. 134 , 135 Inactivation of c-MAF in Treg cells results in the dysfunction of IL-10 production, thus developing spontaneous colitis. 136 IL-10 inhibits IFN-γ production by Th1 cells in mice transferred with CD45RB hi CD4 + T cells, reduces Th17 responses in the dextran sulfate sodium (DSS) model, and enables Treg cells to suppress pathogenic Th17 cell responses in colitis.…”
Section: Immunological Pathogenesis Of Ibdmentioning
confidence: 99%
“…Deletion of the IL-10 gene causes genetically engineered mice to spontaneously develop intestinal inflammation after 3 months of age [ 49 ]. In addition, nonsteroidal anti-inflammatory drugs such as piroxicam and sulindac have been recently used to accelerate and synchronize the onset of colitis [ 50 ]. Spontaneous and unremitting inflammation is driven by a Th1 T cell response that causes infiltration of lymphocytes, macrophages, and neutrophils in the colon.…”
Section: Genetically Engineered Modelsmentioning
confidence: 99%
“…49 In addition, nonsteroidal anti-inflammatory drugs such as piroxicam and sulindac have been recently used to accelerate and synchronize the onset of colitis. 50 Spontaneous and unremitting inflammation is driven by a Th1 T cell response that causes infiltration of lymphocytes, macrophages, and neutrophils in the colon. It has been revealed that the enteric microbiome plays a crucial role in immune system activation in IL-10 KO mice.…”
Section: Genetically Engineered Models Of Chronic Colitismentioning
confidence: 99%